Clorox Company (The) (CLX)

CLX Quantitative Snapshot

Academic risk and quality models computed from CLX's own filings and price history, not from analyst opinion.

Piotroski F-Score

3 / 9

Weak: only 3 of 9 fundamental-health tests pass, which is the range associated with deteriorating fundamentals.

Altman Z-Score

2.19

Altman Z in the 1.81 to 2.99 grey zone, the band where the model gives no clear bankruptcy verdict.

Beneish M-Score

-3.45

Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.

Sloan Accrual Ratio

-0.003

Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.

Market Regime (HMM)

Sideways · 32% confidence

Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.

Forecast Volatility (30d)

34.6%

GARCH(1,1) 30-day annualised forecast, above the current 34.1% reading.

Market Beta (5-factor)

0.70

Fama-French 5-factor market beta. The five factors explain 23% of this stock's return variance; the rest is idiosyncratic.

Own 5-Year Median P/E

39.3

The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.

Model inputs as of 2026-09-08.